Clinic-based study of plexiform neurofibromas in neurofibromatosis 1

被引:0
|
作者
Waggoner, DJ
Towbin, J
Gottesman, G
Gutmann, DH
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] St Louis Childrens Hosp, Dept Med Genet, Neurofibromatosis Program, St Louis, MO 63178 USA
[3] St Louis Univ, Cardinal Glennon Childrens Hosp, Dept Med Genet, St Louis, MO USA
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2000年 / 92卷 / 02期
关键词
neurofibromatosis; 1; plexiform neurofibroma; cancer; tumor;
D O I
10.1002/(SICI)1096-8628(20000515)92:2<132::AID-AJMG10>3.0.CO;2-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Individuals with neurofibromatosis 1 (NF1) develop both benign and malignant tumors at an increased frequency. One of the most common benign tumors in NF1 is the plexiform neurofibroma, These tumors cause significant morbidity and mortality on account of their propensity to grow and affect adjacent normal tissues. To determine the clinical profile of plexiform neurofibromas in NF1, we conducted a retrospective review of 68 NF1 patients with plexiform neurofibroma, In our series, 44% of tumors were detected by 5 years of age and most were located in the trunk and extremities. Only two patients developed malignant peripheral nerve sheath tumors in their preexisting plexiform neurofibromas, Lastly, we demonstrate that there were no specific clinical features of NF1 associated with the presence of plexiform neurofibroma, These results underscore the importance of careful serial examinations in the evaluation of patients with NF1. Am. J. Med. Genet. 92:132-135, 2000, (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:132 / 135
页数:4
相关论文
共 50 条
  • [31] Neurofibromatosis Type 1 Presenting with Plexiform Neurofibromas in Two Patients: MRI Features
    Halefoglu, Ahmet Mesrur
    CASE REPORTS IN MEDICINE, 2012, 2012
  • [32] Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience
    Espirito Santo, Vera
    Passos, Joao
    Nzwalo, Hipolito
    Carvalho, Ines
    Santos, Filipa
    Martins, Carmo
    Salgado, Lucilia
    Silva, Conceicao e
    Vinhais, Sofia
    Vilares, Miguel
    Salgado, Duarte
    Nunes, Sofia
    JOURNAL OF NEURO-ONCOLOGY, 2020, 147 (02) : 459 - 463
  • [33] QUALITY OF LIFE FOR PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 ASSOCIATED PLEXIFORM NEUROFIBROMAS (PNF)
    Lai, J.
    Beaumont, J. L.
    Jensen, S.
    VALUE IN HEALTH, 2017, 20 (09) : A727 - A727
  • [34] Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Frequency and Associated Clinical Deficits
    Rosa Nguyen
    Kluwe, Lan
    Fuensterer, Carsten
    Kentsch, Michael
    Friedrich, Reinhard Edgar
    Mautner, Victor-Felix
    JOURNAL OF PEDIATRICS, 2011, 159 (04): : 652 - 655
  • [35] Surgical Management of "Kissing" Spinal Plexiform Neurofibromas in Neurofibromatosis Tyne 1 Patient
    Shofty, Ben
    Mauda-Havakuk, Michal
    Ben-Sira, Liat
    Bokstein, Felix
    Lidar, Zvi
    Salame, Khalil
    Korn, Akiva
    Constantini, Shlomi
    WORLD NEUROSURGERY, 2020, 134 : E1143 - E1147
  • [36] The developmental trajectory of cognitive functioning in children with neurofibromatosis type 1 and plexiform neurofibromas
    Barton, Belinda
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2020, 62 (08): : 892 - 892
  • [37] Management of head and neck plexiform neurofibromas in pediatric patients with neurofibromatosis type 1
    Wise, JB
    Cryer, JE
    Belasco, JB
    Jacobs, I
    Elden, L
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2005, 131 (08) : 712 - 718
  • [38] Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience
    Vera Espírito Santo
    João Passos
    Hipólito Nzwalo
    Inês Carvalho
    Filipa Santos
    Carmo Martins
    Lucília Salgado
    Conceição e Silva
    Sofia Vinhais
    Miguel Vilares
    Duarte Salgado
    Sofia Nunes
    Journal of Neuro-Oncology, 2020, 147 : 459 - 463
  • [39] Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial
    Michael J. Fisher
    Chie-Schin Shih
    Steven D. Rhodes
    Amy E. Armstrong
    Pamela L. Wolters
    Eva Dombi
    Chi Zhang
    Steven P. Angus
    Gary L. Johnson
    Roger J. Packer
    Jeffrey C. Allen
    Nicole J. Ullrich
    Stewart Goldman
    David H. Gutmann
    Scott R. Plotkin
    Tena Rosser
    Kent A. Robertson
    Brigitte C. Widemann
    Abbi E. Smith
    Waylan K. Bessler
    Yongzheng He
    Su-Jung Park
    Julie A. Mund
    Li Jiang
    Khadijeh Bijangi-Vishehsaraei
    Coretta Thomas Robinson
    Gary R. Cutter
    Bruce R. Korf
    Jaishri O. Blakeley
    D. Wade Clapp
    Nature Medicine, 2021, 27 : 165 - 173
  • [40] A Review of Selumetinib in the Treatment of Neurofibromatosis Type 1-Related Plexiform Neurofibromas
    Anderson, Mary Kate
    Johnson, Meredith
    Thornburg, Lauren
    Halford, Zachery
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (06) : 716 - 726